A clear cut association between CCND1 amplification and patients’ outcome in female breast cancer is lacking, but CCND1 amplification may be associated with a poor prognosis, particularly in ER positive tumors [23, 24, 33–35]. This evidence concerns the gene CCND1 and breast cancer.